May 1 |
TriSalus Life Sciences secures ~$50M of debt financing with OrbiMed
|
Apr 30 |
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives
|
Apr 1 |
TriSalus Life Sciences, Inc. (TLSI) Q4 2023 Earnings Call Transcript
|
Apr 1 |
TriSalus Life Sciences GAAP EPS of -$1.56
|
Apr 1 |
TriSalus Life Sciences Inc (TLSI) Q4 and Full Year 2023 Earnings: Revenue Growth Amidst Late ...
|
Apr 1 |
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
|
Apr 1 |
Earnings Scheduled For April 1, 2024
|